Avricore Health Inc.
corporate_fare Company Profile
Avricore Health Inc. (OTC:AVCRF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for AVCRF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-09, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for AVCRF spans 6-K.
Recent high-impact activity:
- HealthTab™ Goes National: NHS England Backs Avricore's Pharmacy Cholesterol Testing
- Avricore Signs Multi-Year Abbott Deal for UK Point-of-Care Testing
- Avricore Health Closes Upsized $1.254M Private Placement with Insider Participation
- Avricore Health Secures $1.25M Private Placement to Address Going Concern
- Avricore Health Faces Going Concern Warning Amidst 89% Revenue Drop and Increased Losses
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for AVCRF, detected from its recent SEC filings · based on capital-structure filings through 2026-07-11.
Private Placement Closed · Insider Participation
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
AVCRF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.